New Trump tariffs on pharmaceuticals could double the cost of common prescription drugs, raising prices for medications like ...

Novartis believes its heart failure drug Entresto's clinical data, commercial infrastructure and recognition among cardiologists can help it fend off potential competition from Eli Lilly and ...

Entresto, a combination of an old drug valsartan with a novel neprilysin inhibitor sacubitril from Novartis, which was approved in July for treating heart failure, has been ear-marked by analysts as a ...

If you’re looking at treatment options for heart failure, you may want to learn more about Entresto (sacubitril/valsartan). It’s a prescription drug used to treat ...

Entresto is a brand-name prescription medication containing sacubitril and valsartan. The FDA approved generic versions of Entresto in May 2024, and the drug was launched in July 2025. According to ...

A new suit against Novartis comes as the Swiss pharma is trying to fend off several Entresto generic contenders with lawsuits. (Novartis) Novartis is already suing a long list of generics producers ...

The European Commission’s (or EC) approval of Entresto (sacubitril/valsartan) on November 24, 2015, for symptomatic chronic heart failure with reduced ejection ...

Entresto is the first-in-class angiotensin receptor neprilysin inhibitor therapy (or ARNI), which has been approved in the US and Europe for patients suffering from symptomatic chronic heart failure ...

FRANKFURT (Reuters) - Swiss drugmaker Novartis raised its 2024 earnings guidance for the second time on Thursday, driven by a gain in prescriptions for drugs including heart failure treatment Entresto ...

I've lost about 25 pounds.

Entresto (sacubitril/valsartan) has interactions with alcohol, other medications, and some supplements. For example, Entresto can interact with potassium supplements ...

ENTRESTO The FDA has approved Entresto for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged 1 year and older. The Food and Drug ...